Warner Chilcott Sued Over Loestrin Pay-For-Delay Deals

Law360, New York (April 08, 2013, 1:54 PM ET) -- Warner Chilcott PLC was hit with a class action on Friday alleging the drugmaker violated U.S. antitrust laws when it agreed to settle "sham" patent infringement litigation against Lupin Pharmaceuticals Inc. and Watson Pharmaceuticals Inc. that delayed entry of generic versions of oral contraceptive Loestrin.

The lawsuit, brought by a union representing food workers in Pennsylvania, claims the settlements guaranteed Loestrin 24 Fe wouldn't have to compete against lower-cost alternatives up until the deal with Watson expires in January 2014 — six months before a Warner...
To view the full article, register now.